Correlative studies of bone marrow samples from patients who received DLI for relapsed CML have identified enhanced infiltration of CD8 T cells and reversal of exhaustion in patients with effective GVL after DLI, in a mechanism similar to that seen in other tumor settings with ICB (212). This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.